Latest Insider Transactions at Vir Biotechnology, Inc. (VIR)
This section provides a real-time view of insider transactions for Vir Biotechnology, Inc. (VIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vir Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vir Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2025
|
Vanina De Verneuil EVP, General Counsel, Corp Sec |
SELL
Open market or private sale
|
Direct |
2,385
-2.96%
|
$11,925
$5.16 P/Share
|
|
Nov 03
2025
|
Vanina De Verneuil EVP, General Counsel, Corp Sec |
SELL
Open market or private sale
|
Direct |
1,365
-1.67%
|
$6,825
$5.86 P/Share
|
|
Nov 03
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.79%
|
$110,000
$5.64 P/Share
|
|
Oct 29
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$600
$6.49 P/Share
|
|
Oct 28
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,453
-0.17%
|
$146,718
$6.5 P/Share
|
|
Oct 27
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
66,403
-0.45%
|
$398,418
$6.05 P/Share
|
|
Oct 24
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
46,696
-0.32%
|
$233,480
$5.96 P/Share
|
|
Oct 23
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
154,383
-1.04%
|
$771,915
$5.99 P/Share
|
|
Oct 22
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,266
-0.96%
|
$865,596
$6.15 P/Share
|
|
Oct 21
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
109,675
-0.73%
|
$658,050
$6.3 P/Share
|
|
Oct 20
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
220,535
-1.44%
|
$1,323,210
$6.2 P/Share
|
|
Oct 16
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,844
-0.08%
|
$77,064
$6.1 P/Share
|
|
Oct 15
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,671
-0.11%
|
$100,026
$6.07 P/Share
|
|
Oct 10
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,300
-0.02%
|
$13,800
$6.08 P/Share
|
|
Oct 09
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
249,060
-1.59%
|
$1,494,360
$6.14 P/Share
|
|
Oct 08
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
466,242
-2.9%
|
$2,797,452
$6.05 P/Share
|
|
Oct 07
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
72,133
-0.45%
|
$360,665
$5.6 P/Share
|
|
Oct 06
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
73,955
-0.46%
|
$369,775
$5.69 P/Share
|
|
Oct 03
2025
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
450,342
-2.7%
|
$2,251,710
$5.56 P/Share
|
|
Oct 01
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.75%
|
$110,000
$5.84 P/Share
|
|
Sep 02
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.72%
|
$88,000
$4.99 P/Share
|
|
Aug 01
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.69%
|
$88,000
$4.99 P/Share
|
|
Jul 17
2025
|
Mark Eisner EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,586
-3.31%
|
$17,930
$5.47 P/Share
|
|
Jul 15
2025
|
Mark Eisner EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,796
-5.91%
|
$33,980
$5.47 P/Share
|
|
Jul 01
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.67%
|
$110,000
$5.1 P/Share
|
|
Jun 09
2025
|
Robert J More Director |
BUY
Other acquisition or disposition
|
Indirect |
14,027
+2.68%
|
-
|
|
Jun 09
2025
|
Robert J More Director |
SELL
Other acquisition or disposition
|
Direct |
14,027
-25.65%
|
-
|
|
Jun 06
2025
|
Norbert W Bischofberger Director |
BUY
Other acquisition or disposition
|
Indirect |
10,667
+50.0%
|
-
|
|
Jun 06
2025
|
Norbert W Bischofberger Director |
SELL
Other acquisition or disposition
|
Direct |
10,667
-44.45%
|
-
|
|
Jun 02
2025
|
Janet Napolitano Director |
SELL
Open market or private sale
|
Direct |
3,200
-16.31%
|
$16,000
$5.05 P/Share
|
|
May 30
2025
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.1%
|
-
|
|
May 30
2025
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+28.97%
|
-
|
|
May 30
2025
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+26.13%
|
-
|
|
May 30
2025
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+0.6%
|
-
|
|
May 30
2025
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.1%
|
-
|
|
May 30
2025
|
Robert J More Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+12.76%
|
-
|
|
May 30
2025
|
Norbert W Bischofberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.0%
|
-
|
|
May 30
2025
|
Ramy Farid Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.0%
|
-
|
|
Apr 03
2025
|
Marianne De Backer Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
79,712
-9.39%
|
$398,560
$5.95 P/Share
|
|
Feb 26
2025
|
Vanina De Verneuil EVP, General Counsel, Corp Sec |
SELL
Open market or private sale
|
Direct |
7,373
-8.49%
|
$66,357
$9.14 P/Share
|
|
Feb 24
2025
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,056
-1.42%
|
$90,504
$9.45 P/Share
|
|
Feb 24
2025
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,168
-10.73%
|
$127,512
$9.45 P/Share
|
|
Feb 24
2025
|
Vanina De Verneuil EVP, General Counsel, Corp Sec |
SELL
Open market or private sale
|
Direct |
5,140
-5.59%
|
$46,260
$9.45 P/Share
|
|
Feb 24
2025
|
Marianne De Backer Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,122
-1.86%
|
$145,098
$9.45 P/Share
|
|
Feb 24
2025
|
Brent Sabatini SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,562
-3.24%
|
$14,058
$9.45 P/Share
|
|
Feb 22
2025
|
Jason O'Byrne EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.81%
|
-
|
|
Feb 22
2025
|
Vanina De Verneuil EVP, General Counsel, Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+27.56%
|
-
|
|
Feb 22
2025
|
Marianne De Backer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+21.71%
|
-
|
|
Feb 22
2025
|
Brent Sabatini SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+29.33%
|
-
|
|
Feb 22
2025
|
Mark Eisner EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.81%
|
-
|